4-Nitrobenzyl homoallylamine | 1343858-78-5

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 4-Nitrobenzyl homoallylamine
• 英文别名: N-[(4-nitrophenyl)methyl]but-3-en-1-amine
• CAS: 1343858-78-5
• 化学式: C₁₁H₁₄N₂O₂
• 分子量: 206.244
• InChiKey: ORAPLGAEWVCRCA-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.2
• 重原子数：
  15
• 可旋转键数：
  5
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.27
• 拓扑面积：
  57.8
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  4-Nitrobenzyl homoallylamine 在 Grubbs catalyst first generation 4-二甲氨基吡啶 、 1-(3-二甲基氨基丙基)-3-乙基碳二亚胺 作用下， 生成 methyl 3-(1-(4-nitrobenzyl)-2-oxo-1,2,5,6-tetrahydropyridin-3-yl)propanoate
  参考文献：
  名称：

  Modification of cap group in δ-lactam-based histone deacetylase (HDAC) inhibitors

  摘要：

  Novel delta-lactam-based HDAC inhibitors which have various substituted benzyl, bi-aromatic cap groups were prepared using ring closure metathesis reaction, and evaluated their HDAC inhibitory activities and anti-proliferative effects. Among prepared analogues, 11m and 11o have very strong HDAC enzymatic inhibition and showed the most potent growth inhibitory activity to five human tumor cell lines including PC-3, ACHN, NUGC-3, HCT-15, and MBA-MB-231 tumor cell lines. Compounds 11m and 11o also showed good tumor growth inhibition of MDA-MB-231 cells in in vivo xenograft model. Structure-activity relationship study using docking model explained the significance of hydrophobic aromatic cap groups for their in vitro activities. (C) 2007 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2007.09.034
• 作为产物：
  描述：

  4-溴-1-丁烯 、 4-硝基苄胺 在 N,N-二异丙基乙胺 作用下， 生成 4-Nitrobenzyl homoallylamine
  参考文献：
  名称：

  Modification of cap group in δ-lactam-based histone deacetylase (HDAC) inhibitors

  摘要：

  Novel delta-lactam-based HDAC inhibitors which have various substituted benzyl, bi-aromatic cap groups were prepared using ring closure metathesis reaction, and evaluated their HDAC inhibitory activities and anti-proliferative effects. Among prepared analogues, 11m and 11o have very strong HDAC enzymatic inhibition and showed the most potent growth inhibitory activity to five human tumor cell lines including PC-3, ACHN, NUGC-3, HCT-15, and MBA-MB-231 tumor cell lines. Compounds 11m and 11o also showed good tumor growth inhibition of MDA-MB-231 cells in in vivo xenograft model. Structure-activity relationship study using docking model explained the significance of hydrophobic aromatic cap groups for their in vitro activities. (C) 2007 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2007.09.034

文献信息

• Modification of cap group in δ-lactam-based histone deacetylase (HDAC) inhibitors
  作者：Hwan Mook Kim、Sung Hee Hong、Myung Sook Kim、Chang Woo Lee、Jong Soon Kang、Kiho Lee、Song-Kyu Park、Jeung Whan Han、Hee Yoon Lee、Yongseok Choi、Ho Jeung Kwon、Gyoonhee Han

  DOI：10.1016/j.bmcl.2007.09.034

  日期：2007.11

  Novel delta-lactam-based HDAC inhibitors which have various substituted benzyl, bi-aromatic cap groups were prepared using ring closure metathesis reaction, and evaluated their HDAC inhibitory activities and anti-proliferative effects. Among prepared analogues, 11m and 11o have very strong HDAC enzymatic inhibition and showed the most potent growth inhibitory activity to five human tumor cell lines including PC-3, ACHN, NUGC-3, HCT-15, and MBA-MB-231 tumor cell lines. Compounds 11m and 11o also showed good tumor growth inhibition of MDA-MB-231 cells in in vivo xenograft model. Structure-activity relationship study using docking model explained the significance of hydrophobic aromatic cap groups for their in vitro activities. (C) 2007 Elsevier Ltd. All rights reserved.